• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2019冠状病毒病mRNA疫苗接种后出现的急性重症溃疡性结肠炎：mRNA疫苗会引发炎症性肠病吗？

Acute Severe Ulcerative Colitis After mRNA Coronavirus Disease 2019 Vaccination: Can mRNA Vaccines Unmask Inflammatory Bowel Diseases?

作者信息

Ak Çağatay, Sayar Süleyman, Adalı Gupse, Özdil Kamil

机构信息

Department of Gastroenterology, Health Sciences University Umraniye Training and Research Hospital, İstanbul, Turkey.

出版信息

ACG Case Rep J. 2022 Jul 1;9(7):e00806. doi: 10.14309/crj.0000000000000806. eCollection 2022 Jul.

DOI:10.14309/crj.0000000000000806
PMID:35784512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9246067/
Abstract

BNT162b2 is a messenger RNA vaccine for the prevention of the novel coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 infection. The widespread use of this vaccination has brought along several adverse events. We present a patient with newly diagnosed ulcerative colitis after BNT162b2 vaccine.

摘要

BNT162b2是一种信使核糖核酸疫苗，用于预防由严重急性呼吸综合征冠状病毒2感染引起的2019年新型冠状病毒病。这种疫苗的广泛使用带来了一些不良事件。我们报告了一名在接种BNT162b2疫苗后新诊断为溃疡性结肠炎的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/074f/9246067/6da70877e6ec/ac9-9-e00806-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/074f/9246067/9aa45f662351/ac9-9-e00806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/074f/9246067/1d6a16b76a93/ac9-9-e00806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/074f/9246067/dec829421759/ac9-9-e00806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/074f/9246067/6da70877e6ec/ac9-9-e00806-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/074f/9246067/9aa45f662351/ac9-9-e00806-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/074f/9246067/1d6a16b76a93/ac9-9-e00806-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/074f/9246067/dec829421759/ac9-9-e00806-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/074f/9246067/6da70877e6ec/ac9-9-e00806-g004.jpg

相似文献

1
Acute Severe Ulcerative Colitis After mRNA Coronavirus Disease 2019 Vaccination: Can mRNA Vaccines Unmask Inflammatory Bowel Diseases?2019冠状病毒病mRNA疫苗接种后出现的急性重症溃疡性结肠炎：mRNA疫苗会引发炎症性肠病吗？
ACG Case Rep J. 2022 Jul 1;9(7):e00806. doi: 10.14309/crj.0000000000000806. eCollection 2022 Jul.
2
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines.接种严重急性呼吸综合征冠状病毒 2 载体疫苗和基于 mRNA 的疫苗后，一家三级保健医院工作人员的疫苗接种后感染。
Clin Microbiol Infect. 2022 Apr;28(4):596-601. doi: 10.1016/j.cmi.2021.11.023. Epub 2021 Dec 13.
3
Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports.接种严重急性呼吸综合征冠状病毒 2 疫苗后不久发生的炎性肌病：两例病例报告。
J Med Case Rep. 2022 Jan 30;16(1):57. doi: 10.1186/s13256-022-03266-1.
4
Are the Allergic Reactions of COVID-19 Vaccines Caused by mRNA Constructs or Nanocarriers? Immunological Insights.新冠疫苗的过敏反应是由 mRNA 构建体还是纳米载体引起的？免疫学见解。
Interdiscip Sci. 2021 Jun;13(2):344-347. doi: 10.1007/s12539-021-00438-3. Epub 2021 May 22.
5
Adverse reactions to BNT162b2 mRNA COVID-19 vaccine in medical staff with a history of allergy.有过敏史的医务人员对 BNT162b2 mRNA COVID-19 疫苗的不良反应。
Respir Investig. 2022 Mar;60(2):248-255. doi: 10.1016/j.resinv.2021.11.007. Epub 2021 Dec 7.
6
Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination.接种 BNT162b2 mRNA 冠状病毒 2019 疫苗后出现米勒费希尔综合征。
BMC Neurol. 2021 Nov 18;21(1):452. doi: 10.1186/s12883-021-02489-x.
7
Vaccine-Induced Antibody Responses against SARS-CoV-2 Variants-Of-Concern Six Months after the BNT162b2 COVID-19 mRNA Vaccination.辉瑞-BioNTech 新冠疫苗接种 6 个月后针对 SARS-CoV-2 关注变异株的抗体反应
Microbiol Spectr. 2022 Apr 27;10(2):e0225221. doi: 10.1128/spectrum.02252-21. Epub 2022 Mar 9.
8
Central serous chorioretinopathy following the BNT162b2 mRNA vaccine.接受 BNT162b2 mRNA 疫苗后发生中心性浆液性脉络膜视网膜病变。
J Fr Ophtalmol. 2022 Jun;45(6):597-602. doi: 10.1016/j.jfo.2022.01.006. Epub 2022 May 13.
9
Safety of Inactivated and mRNA COVID-19 Vaccination Among Patients Treated for Hypothyroidism: A Population-Based Cohort Study.甲状腺功能减退症患者接种灭活新冠疫苗和 mRNA 新冠疫苗的安全性：一项基于人群的队列研究。
Thyroid. 2022 May;32(5):505-514. doi: 10.1089/thy.2021.0684. Epub 2022 Apr 7.
10
Short-term safety of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine for patients with advanced lung cancer treated with anticancer drugs: A multicenter, prospective, observational study.抗严重急性呼吸综合征冠状病毒 2 信使 RNA 疫苗在接受抗癌药物治疗的晚期肺癌患者中的短期安全性：一项多中心、前瞻性、观察性研究。
Thorac Cancer. 2022 Feb;13(3):453-459. doi: 10.1111/1759-7714.14281. Epub 2021 Dec 28.

引用本文的文献

1
Acute Severe Colitis after mRNA Coronavirus Disease 2019 Vaccination.2019冠状病毒病mRNA疫苗接种后发生的急性重症结肠炎
Intern Med. 2025 Jan 15;64(2):201-207. doi: 10.2169/internalmedicine.4224-24. Epub 2024 Nov 8.
2
Impact of COVID-19 on Pediatric Inflammatory Bowel Diseases-From Expectations to Reality.新冠病毒病对儿童炎症性肠病的影响——从期望到现实
J Pers Med. 2024 Apr 9;14(4):399. doi: 10.3390/jpm14040399.
3
Cytokine and chemokine profiles in ulcerative colitis relapse after coronavirus disease 2019 vaccination.2019冠状病毒病疫苗接种后溃疡性结肠炎复发时的细胞因子和趋化因子谱

本文引用的文献

1
Acute autoimmune-like hepatitis with atypical anti-mitochondrial antibody after mRNA COVID-19 vaccination: A novel clinical entity?mRNA COVID-19 疫苗接种后出现急性自身免疫样肝炎伴非典型抗线粒体抗体：一种新的临床实体？
J Autoimmun. 2021 Sep;123:102706. doi: 10.1016/j.jaut.2021.102706. Epub 2021 Jul 15.
2
Vitiligo in a COVID-19-vaccinated patient with ulcerative colitis: coincidence?一名患有溃疡性结肠炎的COVID-19疫苗接种者出现白癜风：是巧合吗？
Clin Exp Dermatol. 2022 Jan;47(1):143-144. doi: 10.1111/ced.14842. Epub 2021 Aug 3.
3
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.
J Clin Biochem Nutr. 2024 Mar;74(2):127-135. doi: 10.3164/jcbn.23-26. Epub 2023 Sep 16.
4
An Elderly Patient Developed Ulcerative Colitis after SARS-CoV-2 mRNA Vaccination: A Case Report and Review of the Literature.一位老年患者在接种 SARS-CoV-2 mRNA 疫苗后出现溃疡性结肠炎：病例报告及文献复习。
Intern Med. 2024 Mar 15;63(6):809-814. doi: 10.2169/internalmedicine.2891-23. Epub 2024 Jan 2.
5
Management of Ulcerative Colitis Flare-Ups in the Era of COVID-19.COVID-19时代溃疡性结肠炎发作的管理
Cureus. 2022 Dec 3;14(12):e32153. doi: 10.7759/cureus.32153. eCollection 2022 Dec.
2020年12月14日至2021年1月18日美国接种mRNA新冠疫苗后发生过敏反应的报告
JAMA. 2021 Mar 16;325(11):1101-1102. doi: 10.1001/jama.2021.1967.
4
Next-Generation Vaccines: Nanoparticle-Mediated DNA and mRNA Delivery.下一代疫苗：基于纳米颗粒的 DNA 和 mRNA 递送。
Adv Healthc Mater. 2021 Apr;10(8):e2001812. doi: 10.1002/adhm.202001812. Epub 2021 Jan 18.
5
Herd Immunity: Understanding COVID-19.群体免疫：了解 COVID-19。
Immunity. 2020 May 19;52(5):737-741. doi: 10.1016/j.immuni.2020.04.012.
6
Nucleic acid-sensing TLRs and autoimmunity: novel insights from structural and cell biology.核酸感应Toll样受体与自身免疫：结构生物学和细胞生物学的新见解
Immunol Rev. 2016 Jan;269(1):60-75. doi: 10.1111/imr.12375.
7
Nucleic acid vaccination strategies against infectious diseases.核酸疫苗策略防治传染病。
Expert Opin Drug Deliv. 2015;12(12):1851-65. doi: 10.1517/17425247.2015.1077559. Epub 2015 Sep 12.
8
Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5.RIG-I 和 MDA5 的模式识别和信号机制。
Front Immunol. 2014 Jul 23;5:342. doi: 10.3389/fimmu.2014.00342. eCollection 2014.
9
NF-kappaB in inflammatory bowel disease.炎症性肠病中的核因子κB
J Intern Med. 2008 Jun;263(6):591-6. doi: 10.1111/j.1365-2796.2008.01953.x.
10
Onset of inflammatory bowel diseases during combined alpha-interferon and ribavirin therapy for chronic hepatitis C: report of two cases.
Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1243-5. doi: 10.1097/00042737-200511000-00015.